GH1 and neoplasm: Tumours showing dense GH granulation on pathology demonstrate greater responsiveness to first-generation SRL therapy than sparsely granulated adenomas45,124,125 (LQ), whereas T2-hyperintense tumours are less likely to respond to SRL therapy than other tumours48,126 (LQ).